Catalent Pharma Solutions is expanding its inhalation drug development, delivery and supply capabilities at its Inhalation Center of Excellence in Research Triangle Park (RTP), NC. The $20 million investment will focus on expanding pressurized Metered Dose Inhaler (pMDI) clinical and commercial supply capabilities.   Catalent provides a broad range of inhalation services including API optimization, pre-formulation, formulation, analytical testing and manufacturing across all inhaled dosage forms...